Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising

Abstract

Advertisements for pharmaceuticals may promote placebo responses by generating an expectation of therapeutic success. Some cite this as reason to favour Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA). Against this, I show placebo responses to emanate from beliefs rendered unjustified by the influence of a conditioning process. I argue that drug safety and efficacy are material properties and that unjustified beliefs in these domains entail costs to autonomy that outweigh any prudential gains attending a placebo response. I conclude that its placebogenic potential ought not to count as reason to favour DTCA.

This is a preview of subscription content, access via your institution.

References

  1. Ader, R. (2003). Conditioned immunomodulation: Research needs and directions. Brain, Behavior, and Immunity, 17(Suppl 1), S51–S57.

    Article  Google Scholar 

  2. Almasi, E. A., Stafford, R. S., Kravitz, R. L., & Mansfield, P. R. (2006). What are the public health effects of direct-to-consumer drug advertising? PLoS Medicine, 3(3), e145.

    Article  Google Scholar 

  3. Amanzio, M., & Benedetti, F. (1999). Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. Journal of Neuroscience, 19(1), 484–494.

    Google Scholar 

  4. Amgen Wyeth. (2004). Enbrel TV Ad. Cited July 11, 2013. http://www.youtube.com/watch?v=7JLN_QR6Wl8.

  5. Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J. K. (2005). Neurobiological mechanisms of the placebo effect. Journal of Neuroscience, 25(45), 10390–10402.

    Article  Google Scholar 

  6. Biegler, P., & Vargas, P. (2013). Ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising. American Journal of Bioethics, 13(5), 3–13.

    Article  Google Scholar 

  7. Bizer, G. Y., Barden, J. C., & Petty, R. E. (2003). Attitudes. In L. Nadel (Ed.), Encyclopedia of cognitive science. Hampshire: MacMillan.

    Google Scholar 

  8. Bok, S. (1974). The ethics of giving placebos. Scientific American, 231(5), 17–23.

    Article  Google Scholar 

  9. Brunstrom, J. M., & Higgs, S. (2002). Exploring evaluative conditioning using a working memory task. Learning and Motivation, 33, 433–455.

    Article  Google Scholar 

  10. Buss, S. (2008). Personal autonomy. The Metaphysics Research Lab, Stanford University. Cited July 11, 2013. http://plato.stanford.edu/entries/personal-autonomy/.

  11. Colloca, L., & Benedetti, F. (2005). Placebos and painkillers: Is mind as real as matter? Nature Reviews Neuroscience, 6(7), 545–552.

    Article  Google Scholar 

  12. De Houwer, J. (2009). Conditioning as a source of liking: There is nothing simple about it. In M. Wanke (Ed.), Social psychology of consumer behavior. New York: Taylor and Francis.

    Google Scholar 

  13. De Houwer, J. (2011). Evaluative conditioning: A review of functional knowledge and mental process theories. In T. R. Schachtman & S. S. Reilly (Eds.), Associative learning and conditioning theory: Human and non-human applications. Oxford: Oxford University Press.

    Google Scholar 

  14. De Houwer, J., Baeyens, F., & Eelen, P. (1994). Verbal evaluative conditioning with undetected US presentations. Behaviour Research and Therapy, 32(6), 629–633.

    Article  Google Scholar 

  15. Eagly, A. H., & Chaiken, S. (1993). The psychology of attitudes. Fort Worth, TX: Harcourt Brace Jovanovich College Publishers.

    Google Scholar 

  16. Eifert, G. H., Craill, L., Carey, E., & O’Connor, C. (1988). Affect modification through evaluative conditioning with music. Behaviour Research and Therapy, 26(4), 321–330.

    Article  Google Scholar 

  17. Faden, R. R., Beauchamp, T. L., & King, N. M. P. (1986). A history and theory of informed consent. New York: Oxford University Press.

    Google Scholar 

  18. Foddy, B. (2009). A duty to deceive: Placebos in clinical practice. American Journal of Bioethics, 9(12), 4–12.

    Article  Google Scholar 

  19. Foley, R. (2008). An epistemology that matters. In P. J. Weithman (Ed.), Liberal faith: Essays in honor of Philip Quinn. Notre Dame, IN: University of Notre Dame Press.

    Google Scholar 

  20. Food and Drug Administration. (2001). Guidance for industry: E 10 Choice of control group and related issues in clinical trials. Rockville.

  21. Giang, D. W., Goodman, A. D., Schiffer, R. B., Mattson, D. H., Petrie, M., Cohen, N., et al. (1996). Conditioning of cyclophosphamide-induced leukopenia in humans. The Journal of Neuropsychiatry and Clinical Neurosciences, 8(2), 194–201.

    Google Scholar 

  22. Gibson, B. (2008). Can evaluative conditioning change attitudes toward mature brands? New evidence from the implicit association test. Journal of Consumer Research, 35, 178–188.

    Article  Google Scholar 

  23. Hahn, R. A. (1997). The nocebo phenomenon: Concept, evidence, and implications for public health. Preventive Medicine, 26(5), 607–611.

    Article  Google Scholar 

  24. Hofmann, W., De Houwer, J., Perugini, M., Baeyens, F., & Crombez, G. (2010). Evaluative conditioning in humans: A meta-analysis. Psychological Bulletin, 136(3), 390–421.

    Article  Google Scholar 

  25. Hrobjartsson, A., & Gotzsche, P. C. (2001). Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine, 344(21), 1594–1602.

    Article  Google Scholar 

  26. Jordan, J. (1996). Pragmatic arguments and belief. American Philosophical Quarterly, 33(4), 409–420.

    Google Scholar 

  27. Kawall, J. (2010). Autonomy, agency, and the value of enduring beliefs. Canadian Journal of Philosophy, 40(1), 107–129.

    Article  Google Scholar 

  28. Kirsch, I. (1985). Response expectancy as a determinant of experience and behavior. American Psychologist, 40(11), 1189–1202.

    Article  Google Scholar 

  29. Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention and Treatment, 1(1), 1–16.

    Google Scholar 

  30. Krosnick, J. A., Jussim, L. J., & Lynn, A. R. (1992). Subliminal conditioning of attitudes. Personality and Social Psychology Bulletin, 18(2), 152–162.

    Article  Google Scholar 

  31. Lang, P. J., Bradley, M. M., & Cuthbert, B. N. (2008). International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-8. Gainesville, FL: University of Florida.

  32. Pavlov, I. (1927). Conditioned reflexes: An investigation of the physiological activity of the cerebral cortex (G. V. Anrep, Trans.). London: Oxford University Press.

  33. Pfizer. Lipitor commercial. Cited July 11, 2013. http://www.youtube.com/watch?v=lNFuEcy5ekg.

  34. Price, D. D., Finniss, D. G., & Benedetti, F. (2008). A comprehensive review of the placebo effect: Recent advances and current thought. Annual Review of Psychology, 59, 565–590.

    Article  Google Scholar 

  35. Price, D. D., Milling, L. S., Kirsch, I., Duff, A., Montgomery, G. H., & Nicholls, S. S. (1999). An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain, 83(2), 147–156.

    Article  Google Scholar 

  36. Reisner, A. (2008). Weighing pragmatic and evidential reasons for belief. Philosophical Studies, 138, 17–27.

    Article  Google Scholar 

  37. The Hastings Center. (1996). The goals of medicine. Setting new priorities. The Hastings Center Report, 26(6), S1–S27.

    Article  Google Scholar 

  38. Rogers v Whitaker. (1992). 67 Australian Law Journal Reports 47.

  39. Roullet, B., & Droulers, O. (2005). Pharmaceutical packaging colour and drug expectancy. Advances in Consumer Research, 32, 164–171.

    Google Scholar 

  40. Rozin, P., Wrzesniewski, A., & Byrnes, D. (1998). The elusiveness of evaluative conditioning. Learning and Motivation, 29, 397–415.

    Article  Google Scholar 

  41. Schneiderman, L. J., Jecker, N. S., & Jonsen, A. R. (1990). Medical futility: Its meaning and ethical implications. Annals of Internal Medicine, 112(12), 949–954.

    Article  Google Scholar 

  42. Shiv, B., Carmon, Z., & Ariely, D. (2005a). Ruminating about placebo effects of marketing actions. Journal of Marketing Research, 42, 410–414.

    Article  Google Scholar 

  43. Shiv, B., Carmon, Z., & Ariely, D. (2005b). Placebo effects of marketing actions: Consumers may get what they pay for. Journal of Marketing Research, 42, 383–393.

    Article  Google Scholar 

  44. Silberman, S. (2009). Placebos are getting more effective. Drugmakers are desperate to know why. Cited July 11, 2013. http://www.wired.com/medtech/drugs/magazine/17-09/ff_placebo_effect?currentPage=all.

  45. Skene, L., & Smallwood, R. (2002). Informed consent: Lessons from Australia. British Medical Journal, 324(7328), 39–41.

    Article  Google Scholar 

  46. Stewart-Williams, S., & Podd, J. (2004). The placebo effect: Dissolving the expectancy versus conditioning debate. Psychological Bulletin, 130(2), 324–340.

    Article  Google Scholar 

  47. Sweldens, S., Van Osselaer, S. M. J., & Janiszewski, C. (2010). Evaluative conditioning procedures and the resilience of conditioned brand attitudes. Journal of Consumer Research, 37(October), 473–489.

    Article  Google Scholar 

  48. Swinburne, R. (2001). Epistemic justification. New York: Oxford University Press.

    Google Scholar 

  49. Tilburt, J. C., Emanuel, E. J., Kaptchuk, T. J., Curlin, F. A., & Miller, F. G. (2008). Prescribing “placebo treatments”: Results of national survey of US internists and rheumatologists. British Medical Journal, 337, a1938.

    Article  Google Scholar 

  50. Vase, L., Robinson, M. E., Verne, G. N., & Price, D. D. (2003). The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain, 105(1–2), 17–25.

    Article  Google Scholar 

  51. Waber, R. L., Shiv, B., Carmon, Z., & Ariely, D. (2008). Commercial features of placebo and therapeutic efficacy. Journal of the American Medical Association, 299(9), 1016–1017.

    Article  Google Scholar 

  52. Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002). Placebo response in studies of major depression: Variable, substantial, and growing. JAMA, 287(14), 1840–1847.

    Article  Google Scholar 

  53. Walther, E. (2002). Guilty by mere association: Evaluative conditioning and the spreading attitude effect. Journal of Personality and Social Psychology, 82(6), 919–934.

    Article  Google Scholar 

  54. Young, R. (1982). The value of autonomy. The Philosophical Quarterly, 32(126), 35–44.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Paul Biegler.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Biegler, P. Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising. J Bus Ethics 123, 145–155 (2014). https://doi.org/10.1007/s10551-013-1805-0

Download citation

Keywords

  • Pharmaceutical
  • Advertising
  • Placebo
  • Ethics
  • Autonomy